MANAGEMENT OF CHILDREN AND ADOLESCENTS WITH IMMUNETHROMBOCYTOPENIC PURPURA BETWEEN THE YEARS 2001–2006
AbstractBACKGROUND We have analysed the duration time of immune thrombocytopenic purpura (ITP) inchildren and the influence of various risk factors such as: age at diagnosis, sex, onset ofsymptoms and platelet count at diagnosis on duration of ITP. Data of diagnostic workupand type of treatment in child with ITP were analysed.Patients and Data of 64 children with ITP, 29 boys and 35 girls who have been managed at Departmentmethods of Hematology and Oncology at University Children Hospital in Ljubljana between theyears 2001 to 2006 were analysed. Age at diagnosis was seven weeks to 16.2 years. RESULTS The diagnosis of ITP was made by history, physical examination and peripheral bloodcount. Thrombocytopenia was severe in 42 children, moderate in 8 children and mild in14 children. The remission was not achieved in about one half of the children. Twenty eight children were treated, whereas in 34 children »watch and wait« policy with supportiveadvice was used.Children older than 12 years and those who had mild thrombocytopenia at diagnosis wereat higher risk for developement of chronic ITP. CONCLUSIONS In our study group overall clinical course was benign with good outcome regardless oftreatment type. There were no life threatening events. Management of children with ITPrequires usually nonaggressive diagnostic approach and minimal treatment with medication
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.